MOC — Molecure SA Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Molecure SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	125	1.17	1.61	3.65	2.17
Cost of Revenue
Gross Profit	125	0.984	0.51	-0.449	-1.23
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	51.2	14.9	18.4	35.8	34.5
Operating Profit	73.7	-13.8	-16.8	-32.1	-32.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	73.7	-13.6	-15.3	-28.4	-31.3
Provision for Income Taxes
Net Income After Taxes	68	-13.6	-15.3	-28.4	-31.3
Net Income Before Extraordinary Items
Net Income	68	-13.6	-15.3	-28.4	-31.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	68	-13.6	-15.3	-28.4	-31.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.45	-0.792	-1.09	-1.69	-1.55
Dividends per Share